Pay in 4 interest-free payments of $6.77 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
Months 3 to 6: Weight loss continues but the pace slows compared to the first three months
FDA-approved versions of these medications have demonstrated impressive results in clinical studies, but tirzepatide may produce slightly greater weight loss due to its dual-hormone activation
The standard U-100 insulin syringes are often used for small subcutaneous injections
Cagrilintide is a long-acting amylin analogue that reduces appetite and slows gastric emptying, whilst retatrutide is a triple GLP-1, GIP, and glucagon receptor agonist designed to reduce appetite and increase energy expenditure
US$ 24.11
US$ 27.29
US$ 24.92
US$ 23.59
US$ 26.53
US$ 28.80
